Annals of Surgery
Annals of Surgery is a monthly peer-reviewed medical journal that covers the field of surgery. It was established in 1885 and is published by Lippincott Williams & Wilkins, a division of Wolters Kluwer. The editor-in-chief is Keith D. Lillemoe, MD, who is the surgeon-in-chief at Massachusetts General Hospital and the W. Gerald Austen Professor of Surgery at Harvard Medical School.
History[edit]
The Annals of Surgery was established in 1885 by L. L. Seaman. The journal was initially published quarterly, but it switched to a monthly publication schedule in 1920. The journal has been published by Lippincott Williams & Wilkins since its inception.
Content[edit]
The Annals of Surgery publishes original research articles, review articles, editorials, and letters to the editor. The journal covers all aspects of surgery, including general surgery, cardiothoracic surgery, vascular surgery, orthopedic surgery, plastic surgery, pediatric surgery, neurosurgery, and transplant surgery. The journal also publishes articles on surgical education and history.
Impact[edit]
The Annals of Surgery is considered one of the most prestigious journals in the field of surgery. According to the Journal Citation Reports, the journal has a 2019 impact factor of 10.130, ranking it first out of 198 journals in the category "Surgery".
Abstracting and indexing[edit]
The Annals of Surgery is abstracted and indexed in PubMed, MEDLINE, Scopus, and the Science Citation Index. The journal is also available in electronic format.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian